Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001127602-25-009072)

Filing Details

Accession Number:: 0001127602-25-009072
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2025-03-11 16:28:27
Reporting Period:: 2025-03-10

Filing Date:: 2025-03-11
Accepted Time:: 2025-03-11 16:28:27
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1326732	Xencor Inc	XNCR	Pharmaceutical Preparations (2834)	201622502

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1891344	Nancy Valente	C/O Xencor, Inc. 465 N Halstead Street, Suite 200 Pasadena CA 91107	Evp, Chief Development Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2025-03-10	2,565	$13.60	53,785	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

Represents the disposition of shares that were sold to pay withholding taxes upon vesting of 6,544 restricted stock units.
Includes the following shares acquired by the Reporting Person pursuant to the Issuer's Employee Stock Purchase Plan: 1,235 shares acquired on June 10, 2024.